The myeloma-derived gp96 loaded DCs were used to generate tumor-specific CTLs that were able to lyse myeloma tumor cells but not normal blood cells in a MHC class I restricted manner [47, 48]. The gene discussed is HSP90B1; the disease is plasma cell myeloma.